Eculizumab Therapy in Children with Severe Hematopoietic Stem Cell Transplantation–Associated Thrombotic Microangiopathy-Reference-Cited by-同舟云学术

Eculizumab Therapy in Children with Severe Hematopoietic Stem Cell Transplantation–Associated Thrombotic Microangiopathy

Published:2014-04 Issue:4 Volume:20 Page:518-525
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Jodele Sonata,Fukuda Tsuyoshi,Vinks Alexander,Mizuno Kana,Laskin Benjamin L.,Goebel Jens,Dixon Bradley P.,Teusink Ashley,Pluthero Fred G.,Lu Lily,Licht Christoph,Davies Stella M.

Funder

Alexion Pharmaceuticals, Inc

American Society for Blood and Marrow Transplantation/Genentech New Investigator Award

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference34 articles.

1. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy;Laskin;Blood,2011

2. Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?;Batts;Bone Marrow Transplant,2007

3. Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment;Hingorani;J Am Soc Nephrol,2006

4. Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation;Nakamae;Am J Hematol,2006

5. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation;Ho;Biol Blood Marrow Transplant,2005

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombotic complications after hematopoietic stem cell transplantation and other cellular therapies;Thrombosis Update;2024-09

2. Hemostasis and complement in allogeneic hematopoietic stem cell transplantation: clinical significance of two interactive systems;Bone Marrow Transplantation;2024-07-14

3. Transplant-associated thrombotic microangiopathy in pediatrics: incidence, risk factors, therapeutic options, and outcome based on data from a single center;Frontiers in Oncology;2024-07-10

4. Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC);Transplantation and Cellular Therapy;2024-06

5. Prevention and management of acute toxicities from conditioning regimens during hematopoietic stem cell transplantation;Clinical Hematology International;2024-04-03